Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating surgery with or without darolutamide in high-risk and/or locally advanced prostate cancer. The stud…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer [NA]
A National Cancer Institute study is using multiparametric MRI and genomic profiling to evaluate disease progression in men with prostate ca…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [NA]
The Canadian Cancer Trials Group reports an active, not-recruiting trial evaluating local ablative therapy for hormone-sensitive oligometast…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
This clinical trial update describes care considerations for patients with prostate cancer and outlines plans for prospective procurement of…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments [NA]
This completed clinical trial examined whether providing education influences treatment decision making for men with prostate cancer receivi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer [NA]
A completed clinical trial evaluated the acceptability of using artificial intelligence for diagnosing prostate cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Adherence to Oral Therapies in Advanced Breast and Prostate Cancers [NA]
A completed clinical trial update examining adherence to oral therapies in patients with advanced breast cancer and advanced prostate cancer…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
EMA approval · 2026-03-26EMA Authorised: Xtandi (enzalutamide) — Astellas Pharma Europe B.V.
The European Medicines Agency authorised Xtandi (enzalutamide) for prostate cancer, with Astellas Pharma Europe B.V. as the MAH (decision da…
-
EMA approval · 2026-03-26EMA Authorised: Axumin (fluciclovine (18F)) — Blue Earth Diagnostics Ireland Ltd
The European Medicines Agency authorised Axumin (fluciclovine (18F)) for radionuclide imaging in prostate cancer, marking its market access …
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy [Phase 3]
Phase 3 clinical trial update evaluating the optimal timing of the PET tracer rhPSMA-7.3 (18F) to identify sites of recurrent prostate cance…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Flow- Versus Volume-controlled Ventilation During Robot-assisted Laparoscopic Radical Prostatectomy [NA]
This clinical trial update reports a completed study comparing flow-controlled versus volume-controlled ventilation during robot-assisted la…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods [NA]
The clinical trial completed and posted results evaluating an educational intervention intended to increase knowledge about prostate cancer …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
A clinical trial is evaluating a plasma exoRNA-based liquid biopsy to diagnose clinically significant prostate cancer and is currently recru…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of a novel hormone therapy combined with local treatment. Treatment decisions are guided by PSM…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) [NA]
This clinical trial update describes the RTIRE study combining radiation therapy and irreversible electroporation for intermediate-risk pros…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy [Phase 2]
Phase 2 clinical trial evaluating enzalutamide in combination with the ADC PDS01ADC for PET-positive recurrent prostate cancer in patients n…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer [Phase 2]
A Phase 2 study is evaluating in-home versus in-clinic cancer therapy delivery for Black men with locally advanced, biochemically recurrent,…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance
A completed clinical trial evaluated a tailored polygenic risk score to predict progression in men with prostate cancer on active surveillan…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
This clinical trial update describes implementing a new algorithm for HRR gene mutation testing in metastatic prostate cancer patients using…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease [Phase 2]
A Phase 2 clinical trial evaluating intensified 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer with low PSMA exp…
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy [NA]
The clinical trial evaluating intrarectal ice to reduce pain, anxiety, cortisol, complications, and readmission during transrectal ultrasoun…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating Rezvilutamide with radical prostatectomy and metastasis-directed therapy for oligometastatic prostate cancer; curre…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Effect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted Prostatectomy
This clinical trial study investigates the effect of steep Trendelenburg position with pneumoperitoneum on optic nerve sheath diameter durin…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer [NA]
Clinical trial update reporting on completed study comparing hypo-fractionated IMRT versus conventional IMRT for unfavorable intermediate- a…